Safety, PK and PD Study of ABX464 in Untreated HIV Patients

Clinical trial NCT02452242 · COMPLETED

Trial details

NCT number: NCT02452242
Sponsor: Abivax S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Infections

Start date: 2015-01-01
Primary completion: 2015-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.